Radioimmunoassays (RIA) have been shown to be unreliable in measuring serum thyroglobulin levels in patients with antithyroglobulin antibodies. The aim of this study was twofold. Firstly to compare the abilities of two immunoradiometric assays (IRMA), one commercially available, the other an ‘in house’ assay, with a conventional RIA. In addition the prognostic value of serum thyroglobulin levels in patients likely to relapse following a course of antithyroid drugs for Graves' disease was examined.
The results obtained showed both of the IRMA methods to be unaffected by the presence of antithyroglobulin antibodies. Serum thyroglobulin levels were found to be poor predictors of relapse or remission following a 12 month course of antithyroid drugs.
References
1.
Van HerleAJUllerRP. Elevated seum thyroglobulin. A marker for metastases in differentiated thyroid carcinomas. J Clin Invest1975; 56: 272–7.
2.
KawamuraSKishinoBTajimaKMashitaKTaruiS.Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy. J Clin Endocrinol Metab1983; 56: 507–12.
3.
BlackEGGimletteTMDMaiseyMNCassaniAHarmerCLOatesGD. Serum thyroglobulin in thyroid cancer. Lancet1981; 1: 443–5.
4.
SchneiderABLineBRGoldmanJM. Sequential serum thyroglobulin determinations, 131I scan and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab1981; 53: 1199–206.
BayerMBKrissJP. Immunoradiometric assay for serum thyroglobulin: Semi-quantitative measurement of thyroglobulin in antithyroglobulin positive sera. J Clin Endocrinol Metab1979; 49: 557–64.
7.
UllerRPVan HerleAJ. Effect of therapy on serum thyroglobulin levels in patients with Graves' disease. J Clin Endocrinol Metab1978; 46: 747–55.
8.
SchneiderABPervosR.Radioimmunoassay of human thyroglobulin. Effect of antithyroglobulin antibodies. J Clin Endocrinol Metab1978; 47: 126–37.
9.
BlackEGHoffenbergR.Should one measure serum thyroglobulin in the presence of antithyroglobulin antibodies?Clin Endocrinol1983; 19: 597–601.
10.
RatcliffeJRAyoubLAWPearsonDW. The measurement of serum thyroglobulin in the presence of thyroglobulin antibodies. Clin Endocrinol1981; 15: 507–18.
11.
Van HerleAJUllerAPMathewsALBrownJ.Radioimmunoassay for the measurement of thyroglobulin in human serum. J Clin Invest1973; 52: 1320–7.
12.
BaumstarkJSBardaurilWA. A preparative method for the separation of 7S gamma globulin from human serum. Arch Biochem Biophys1964; 108: 514–22.
13.
RodgersRPC. Quality control and data analysis in binder ligand assay 1981. vol 2. Scientific Newsletter, Anaheim, California.
14.
KostrupJFeldt-RasmustenUBaitromHRWilterJSand-HansenH.An enzyme linked immunosorbent assay (ELISA) for measurement of human serum thyroglobulin. Evaluation of the influence of thyroglobulin antibodies. Scand J Clin Lab Invest1985; 45: 471–6.
15.
Feldt-RasmussenUHoltenISand-HansenH.Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer. Cancer1983; 51: 2240–4.
16.
IzumiMLarsenPR. Correlation of sequential changes in serum thyroglobulin, tri-iodothyronine and thyroxine in patients with Graves' disease and subacute thyroiditis. Metabolism1978; 27: 449–60.
17.
GardnerDFRothmanJUtigerR.Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves' disease. Clin Endocrinol1979; 11: 505–91.
18.
WilsonRMcKillopJHPearsonDWCuthbertGFThomsonJA. Relapse of Graves' disease after medical therapy: Predictive value of thyroid technetium-99m uptake and thyroid stimulating hormone receptor antibody levels. J Nucl Med1985; 26: 1024–8.
